Moomoo AIのまとめ
On April 10, 2024, Shah Capital Management, Inc., Shah Capital Opportunity Fund LP, and Himanshu H. Shah, collectively referred to as the Reporting Persons, filed an amended Schedule 13D/A with the SEC regarding their investment in Novavax, Inc. The Reporting Persons now collectively own 6.66%, 6.21%, and 6.70% of Novavax's outstanding shares, respectively. The shares were acquired for investment purposes in the ordinary course of business, with no current plans to influence or control the company's operations. The Reporting Persons may engage in discussions with Novavax's management, other shareholders, or third parties regarding potential changes in operations, strategy, or corporate structure. The Reporting Persons have also entered into a Joint Filing Agreement, indicating their collaborative approach to the filing. The filing emphasizes that, except for the shares directly owned by Himanshu H. Shah, all shares were purchased using the investment capital of the Reporting Persons through open market transactions.
On April 10, 2024, Shah Capital Management, Inc., Shah Capital Opportunity Fund LP, and Himanshu H. Shah, collectively referred to as the Reporting Persons, filed an amended Schedule 13D/A with the SEC regarding their investment in Novavax, Inc. The Reporting Persons now collectively own 6.66%, 6.21%, and 6.70% of Novavax's outstanding shares, respectively. The shares were acquired for investment purposes in the ordinary course of business, with no current plans to influence or control the company's operations. The Reporting Persons may engage in discussions with Novavax's management, other shareholders, or third parties regarding potential changes in operations, strategy, or corporate structure. The Reporting Persons have also entered into a Joint Filing Agreement, indicating their collaborative approach to the filing. The filing emphasizes that, except for the shares directly owned by Himanshu H. Shah, all shares were purchased using the investment capital of the Reporting Persons through open market transactions.
2024年4月10日、Shah Capital Management、Inc.、Shah Capital Opportunity Fund LP、およびHimanshu H. ShahをまとめてReporting Personsと呼び、Novavax, Inc.への投資に関する改訂されたスケジュール13D/AをSECに提出しました。Reporting Personsは現在、それぞれNovavaxの発行済み株式の6.66％、6.21％、および6.70％を所有しています。Reporting Personsは、現在、同社の運営に影響を与えるまたは管理するための計画はなく、ビジネスの日常的な運用におい...すべて展開
2024年4月10日、Shah Capital Management、Inc.、Shah Capital Opportunity Fund LP、およびHimanshu H. ShahをまとめてReporting Personsと呼び、Novavax, Inc.への投資に関する改訂されたスケジュール13D/AをSECに提出しました。Reporting Personsは現在、それぞれNovavaxの発行済み株式の6.66％、6.21％、および6.70％を所有しています。Reporting Personsは、現在、同社の運営に影響を与えるまたは管理するための計画はなく、ビジネスの日常的な運用において投資目的で株式を取得しました。Reporting Personsは、運営や戦略、企業構造の潜在的な変更に関して、Novavaxの経営陣、他の株主、または第三者と議論する可能性があります。Reporting Personsは、共同提出契約に署名しており、提出に協力していることを示しています。提出では、Himanshu H. Shahが直接所有している株式以外は、Reporting Personsの投資資本を使用してオープンマーケット取引を通じて購入されたことを強調しています。
役に立った
役に立たない
